New posts

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

Thread starter News (English) - World Health Organization
Start date Yesterday at 4:07 AM

Yesterday at 4:07 AM

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Share

Copy link

To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.

Continue reading...

Click to expand...

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Already have an account? Log in here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

We value your privacy

We use essential cookies to make this site work, and optional cookies to enhance your experience. You can accept all cookies, reject optional cookies, or configure your preferences to choose which cookies to allow.

See further information and configure your preferences

Accept all cookies Reject optional cookies
Essential cookies

Required for core functionality, such as security, network management, and accessibility. You may not reject these cookies.

Optional cookies

Enable enhanced functionality and a personalized experience. If you reject these, certain functionalities may be unavailable.

Third-party cookies

Set by third-party service providers for purposes such as security, analytics, performance, and advertising. These cookies may also track your interaction with embedded media.

Detailed cookie usage

Privacy policy

Back

Top Bottom

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

We value your privacy